Vimarsana
Biggest News Aggregation in the World

Xin Yao News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xin Yao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xin Yao Today - Breaking & Trending Today

Opening ceremony for Lingnan University Institute for Advanced Study to attract world-class scholars - Vimarsana News

Opening ceremony for Lingnan University Institute for Advanced Study to attract world-class scholars

HONG KONG SAR - Media OutReach Newswire - 26 March 2024 - Lingnan University announced today (26 March) the establishment of the Lingnan University Institute

Aptar China Wins sHero "Leading DEI Best Company Awards 2021 x Inclusion" Award - Vimarsana News

Aptar China Wins sHero "Leading DEI Best Company Awards 2021 x Inclusion" Award

SHero announced this year’s “Leading DEI Best Company Awards 2021” winners, honoring companies that have exceptional success in implementing DEI in corporate China. Aptar China won the “Leading DEI Best Company Awards 2021 x Inclusion” Award. Xin Yao, Vice President and General Manager of Aptar Pharma Northeast Asia, won the “Leading DEI Best People Awards 2021 x 40above40” award.

Source: aptar.com
Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent - Vimarsana News

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent

Share this article Share this article TORONTO, May 3, 2021 /PRNewswire/ -  Mountain Valley MD Holdings Inc. (the " Company" or " MVMD") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce that the Company has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials with third-party cancer Contract Research Organizations (CROs) in triple-negative breast cancer, metastatic melanoma, and lung carcinoma. Summary MVMD files cancer patent for direct intratumoral injection, intravenously, infusions or instillations as adjuvants for broad chemotherapeutic to immunot...